Literature DB >> 18598263

Age-related changes in dopamine transporters and accumulation of 3-nitrotyrosine in rhesus monkey midbrain dopamine neurons: relevance in selective neuronal vulnerability to degeneration.

N M Kanaan1, J H Kordower, T J Collier.   

Abstract

Aging is the strongest risk factor for developing Parkinson's disease (PD). There is a preferential loss of dopamine (DA) neurons in the ventral tier of the substantia nigra (vtSN) compared to the dorsal tier and ventral tegmental area (VTA) in PD. Examining age-related and region-specific differences in DA neurons represents a means of identifying factors potentially involved in vulnerability or resistance to degeneration. Nitrative stress is among the factors potentially underlying DA neuron degeneration. We studied the relationship between 3-nitrotyrosine (3NT; a marker of nitrative damage) and DA transporters [DA transporter (DAT) and vesicular monoamine transporter-2 (VMAT)] during aging in DA subregions of rhesus monkeys. The percentage of DA neurons containing 3NT increased significantly only in the vtSN with advancing age, and the vtSN had a greater percentage of 3NT-positive neurons when compared to the VTA. The relationship between 3NT and DA transporters was determined by measuring fluorescence intensity of 3NT, DAT and VMAT staining. 3NT intensity increased with advancing age in the vtSN. Increased DAT, VMAT and DAT/VMAT ratios were associated with increased 3NT in individual DA neurons. These results suggest nitrative damage accumulates in midbrain DA neurons with advancing age, an effect exacerbated in the vulnerable vtSN. The capacity of a DA neuron to accumulate more cytosolic DA, as inferred from DA transporter expression, is related to accumulation of nitrative damage. These findings are consistent with a role for aging-related accrual of nitrative damage in the selective vulnerability of vtSN neurons to degeneration in PD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18598263      PMCID: PMC3391583          DOI: 10.1111/j.1460-9568.2008.06307.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  43 in total

1.  The efficiency of systematic sampling in stereology--reconsidered.

Authors:  H J Gundersen; E B Jensen; K Kiêu
Journal:  J Microsc       Date:  1999-03       Impact factor: 1.758

Review 2.  Quinone formation as dopaminergic neuron-specific oxidative stress in the pathogenesis of sporadic Parkinson's disease and neurotoxin-induced parkinsonism.

Authors:  Masato Asanuma; Ikuko Miyazaki; Francisco J Diaz-Corrales; Norio Ogawa
Journal:  Acta Med Okayama       Date:  2004-10       Impact factor: 0.892

Review 3.  Oxidative stress and inflammation in Parkinson's disease: is there a causal link?

Authors:  Andreas Hald; Julie Lotharius
Journal:  Exp Neurol       Date:  2005-06       Impact factor: 5.330

4.  Cleavage of alpha-synuclein by calpain: potential role in degradation of fibrillized and nitrated species of alpha-synuclein.

Authors:  Amanda J Mishizen-Eberz; Erin H Norris; Benoit I Giasson; Roberto Hodara; Harry Ischiropoulos; Virginia M-Y Lee; John Q Trojanowski; David R Lynch
Journal:  Biochemistry       Date:  2005-05-31       Impact factor: 3.162

5.  Exogenous erythropoietin provides neuroprotection of grafted dopamine neurons in a rodent model of Parkinson's disease.

Authors:  Nicholas M Kanaan; Timothy J Collier; Deanna M Marchionini; Susan O McGuire; Matthew F Fleming; Caryl E Sortwell
Journal:  Brain Res       Date:  2005-12-20       Impact factor: 3.252

6.  Increased nitrotyrosine immunoreactivity in substantia nigra neurons in MPTP treated baboons is blocked by inhibition of neuronal nitric oxide synthase.

Authors:  R J Ferrante; P Hantraye; E Brouillet; M F Beal
Journal:  Brain Res       Date:  1999-03-27       Impact factor: 3.252

Review 7.  Dopamine transporters and neuronal injury.

Authors:  G W Miller; R R Gainetdinov; A I Levey; M G Caron
Journal:  Trends Pharmacol Sci       Date:  1999-10       Impact factor: 14.819

8.  Metabolism of 3-nitrotyrosine induces apoptotic death in dopaminergic cells.

Authors:  Béatrice Blanchard-Fillion; Delphine Prou; Manuela Polydoro; David Spielberg; Elpida Tsika; Zeneng Wang; Stanley L Hazen; Michael Koval; Serge Przedborski; Harry Ischiropoulos
Journal:  J Neurosci       Date:  2006-06-07       Impact factor: 6.167

Review 9.  Neurodegenerative disorders: the role of peroxynitrite.

Authors:  F Torreilles; S Salman-Tabcheh; M Guérin; J Torreilles
Journal:  Brain Res Brain Res Rev       Date:  1999-08

10.  Functional consequences of alpha-synuclein tyrosine nitration: diminished binding to lipid vesicles and increased fibril formation.

Authors:  Roberto Hodara; Erin H Norris; Benoit I Giasson; Amanda J Mishizen-Eberz; David R Lynch; Virginia M-Y Lee; Harry Ischiropoulos
Journal:  J Biol Chem       Date:  2004-09-09       Impact factor: 5.157

View more
  24 in total

1.  Mosaic aging.

Authors:  Lary C Walker; James G Herndon
Journal:  Med Hypotheses       Date:  2010-01-27       Impact factor: 1.538

Review 2.  Lack of functional relevance of isolated cell damage in transplants of Parkinson's disease patients.

Authors:  Oliver Cooper; Arnar Astradsson; Penny Hallett; Harold Robertson; Ivar Mendez; Ole Isacson
Journal:  J Neurol       Date:  2009-08       Impact factor: 4.849

3.  Aged monkeys as a partial model for Parkinson's disease.

Authors:  P J Hurley; J D Elsworth; M C Whittaker; R H Roth; D E Redmond
Journal:  Pharmacol Biochem Behav       Date:  2011-05-18       Impact factor: 3.533

4.  Fluorogenic tagging of protein 3-nitrotyrosine with 4-(aminomethyl)benzene sulfonate in tissues: a useful alternative to Immunohistochemistry for fluorescence microscopy imaging of protein nitration.

Authors:  V S Sharov; R Pal; E S Dremina; E K Michaelis; C Schöneich
Journal:  Free Radic Biol Med       Date:  2012-08-31       Impact factor: 7.376

5.  Tyrosine Hydroxylase Inhibition in Substantia Nigra Decreases Movement Frequency.

Authors:  Michael F Salvatore; Tamara R McInnis; Mark A Cantu; Deana M Apple; Brandon S Pruett
Journal:  Mol Neurobiol       Date:  2018-07-28       Impact factor: 5.590

6.  Cyclosporine A and MnTMPyP Alleviate α-Synuclein Expression and Aggregation in Cypermethrin-Induced Parkinsonism.

Authors:  Sonal Agrawal; Anubhuti Dixit; Ashish Singh; Pratibha Tripathi; Dhirendra Singh; Devendra Kumar Patel; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2014-11-05       Impact factor: 5.590

Review 7.  α-Synuclein nonhuman primate models of Parkinson's disease.

Authors:  David J Marmion; Jeffrey H Kordower
Journal:  J Neural Transm (Vienna)       Date:  2017-04-22       Impact factor: 3.575

8.  MPTP Induces Systemic Parkinsonism in Middle-Aged Cynomolgus Monkeys: Clinical Evolution and Outcomes.

Authors:  Feng Yue; Sien Zeng; Rongping Tang; Guoxian Tao; Piu Chan
Journal:  Neurosci Bull       Date:  2016-10-03       Impact factor: 5.203

Review 9.  Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease.

Authors:  D James Surmeier; Jaime N Guzman; Javier Sanchez-Padilla
Journal:  Cell Calcium       Date:  2010-01-06       Impact factor: 6.817

10.  The Vulnerable Ventral Tegmental Area in Parkinson's Disease.

Authors:  Stephanie L Alberico; Martin D Cassell; Nandakumar S Narayanan
Journal:  Basal Ganglia       Date:  2015-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.